Delivery Order SPE2DB25D3202-SPE2DB25FTAFN

Award Date 4/28/25
Potential Completion Date 4/29/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for $1,041.42 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide the drug Repatha (140 mg/mL SureClick) to the Defense Logistics Agency (DLA). The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the DLA for global pharmaceutical support. This IDC allows Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support...
This federal contract award, valued at $1,600.08, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the drug Repatha (140 mg/mL) and has an ultimate completion date of August 11, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $1,577.97, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Repatha 140 mg/mL SureClick medication, a cardiovascular treatment. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Repatha, a 140 mg/mL SureClick medication, with a ceiling value of $1,041.42 and a completion date of April 14, 2025. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $1,051.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Repatha 140 mg/ml SureClick, a specialty medication, to support federal healthcare programs. The contract is a Firm Fixed Price Delivery Order, with a period of performance through February 11, 2025. It is not designated as a set-aside contract, indicating open...
This federal contract award, valued at $1,122.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Repatha 140 mg/ml SureClick, a specialty medication used in the treatment of cardiovascular health conditions. The contract has an ultimate completion date of February 10, 2025 and a firm fixed price pricing structure. This contract award is...
This federal contract award, valued at $1,735.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Repatha 140 mg/mL SureClick medication. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 29, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation for this award. The contract is associated with a larger Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,983.94, is a delivery order for the product Repatha 140 mg/ml SureClick. The contract has an ultimate completion date of April 1, 2025. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC...
This federal contract award, valued at $1,051.98, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, is for the supply of Repatha 140 mg/mL SureClick medication. The contract has an ultimate completion date of November 27, 2024. The award was made on a Firm Fixed Price basis, with no...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,041.42 firm-fixed-price delivery order is for the supply of Repatha 140 mg/ml SureClick, a prescription medication. The award has a completion date of May 12, 2025 and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
  • SPE2DB25D3202
    Indefinite Delivery Contract
  • SPE2DB25D3202-SPE2DB25FTAFN
    Delivery Order

This federal contract award, valued at $1,562.13, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Repatha 140 mg/ml SureClick medication, with an ultimate completion date of April 29, 2025.

The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999.00. This IDC, designated as SPE2DX, provides a comprehensive global pharmaceutical support vehicle for the Defense Health Agency, U.S. Coast Guard, and other government agencies, with a performance period extending through December 2026. The contract is not set aside and is open to full and open competition.

Generated 7/28/25, 11:05 AM